Sponsor of the Day:
Jerkmate
https://www.foxnews.com/health/pancreatic-cancer-patient-ben-sasse-sees-massive-tumor-reduction-experimental-drug
Experimental drug doubles survival in metastatic pancreatic cancer trial | Fox News
Apr 28, 2026 - Former Nebraska Sen. Ben Sasse said the experimental drug daraxonrasib has dramatically reduced his pancreatic tumors. Trial data suggests the therapy doubles...
trial fox newsexperimental drugdoubles survivalpancreatic cancermetastatic
https://sciencedaily.com/releases/2024/11/241118125040.htm
High-dose IV vitamin C plus chemotherapy doubles survival in advanced pancreatic cancer |...
A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with...
high doseiv vitaminc plusdoubles survivalpancreatic cancer
https://www.biopharmadive.com/news/revolution-pancreatic-cancer-ras-drug-results/817300/
Revolution pancreatic cancer drug nearly doubles survival in key trial | BioPharma Dive
The subject of buyout rumors this year, Revolution posted Phase 3 results one analyst called a “game changer” in a tough-to-treat tumor.
trial biopharma divepancreatic cancernearly doublesrevolutiondrug